Estimates Revisions BioNTech SE Börse Stuttgart
Stocks
22UA
US09075V1026
Biotechnology & Medical Research
|
Real-time Estimate
Tradegate
07:54:15 20/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 93.15 EUR | -3.62% |
|
+20.06% | +5.28% |
| 08-19 | Moderna, Merck breakthrough could usher in wave of cancer vaccines | RE |
| 08-19 | US stock futures steady after tech slump; investors focus on Middle East tensions | RE |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- BNTX Stock
- 22UA Stock
- Consensus BioNTech SE
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
